STOCKHOLDERS' EQUITY

Accumulated Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive income (loss) are included in the table below.



	Year Ended December 31, 2018
	Unrealized Gains and Losses on Available-for Sale Securities			Foreign Currency Items		Total
	(in thousands)
Beginning balance	$	(23	)	$	122	$	99
Amounts reclassified from accumulated other comprehensive income (loss)	17					17
Ending balance	$	(6	)	$	122	$	116

Stock Repurchase Program

On November 1, 2007, the Company announced its Board authorized the repurchase of up to $50 million of the Company’s common stock. In addition, on October 22, 2014, the Board authorized another $30 million under the share repurchase program. The Company may repurchase its stock for cash in the open market in accordance with applicable securities laws. The timing and amount of any stock repurchase will depend on share price, corporate and regulatory requirements, economic and market conditions, and other factors. The stock repurchase authorization has no expiration date, does not require the Company to repurchase a specific number of shares, and may be modified, suspended, or discontinued at any time.

There were no stock repurchases during the year ended December 31, 2018. During the year ended December 31, 2017, the Company repurchased 48,687 shares for $328,000 at an average cost of $6.73 per share, net of transaction costs through open market repurchases. During the year ended December 31, 2016, the Company repurchased 105,750 shares for $729,000 at an average cost of $6.90 per share, net of transaction costs through open market repurchases. As of December 31, 2018, the program remains available with approximately $33.4 million that may yet be purchased under it.

Stockholders Right Plan

On December 26, 2017, the Board declared a dividend of one right (a “Right”) for each of the Company's issued and outstanding shares of common stock, par value $0.001 per share. The dividend was paid to the stockholders of record at the close of business on January 8, 2018 (the “Record Date”). Each Right entitles the holder to purchase from the Company one one-thousandth of a share of the Company’s Series B Junior Participating Preferred Stock (the “Preferred Stock”) at a price of $30.00 (the “Exercise Price”), subject to certain adjustments and contingently issuable. No shares were issued in connection with this Right, and the Rights expired on December 26, 2018.